These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18363527)

  • 1. Comparison of drug adherence rates among patients with seven different medical conditions.
    Briesacher BA; Andrade SE; Fouayzi H; Chan KA
    Pharmacotherapy; 2008 Apr; 28(4):437-43. PubMed ID: 18363527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence and use of generic drug therapies.
    Briesacher BA; Andrade SE; Fouayzi H; Chan KA
    Am J Manag Care; 2009 Jul; 15(7):450-6. PubMed ID: 19589012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient characteristics associated with medication adherence.
    Rolnick SJ; Pawloski PA; Hedblom BD; Asche SE; Bruzek RJ
    Clin Med Res; 2013 Jun; 11(2):54-65. PubMed ID: 23580788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of medication adherence on hospitalization risk and healthcare cost.
    Sokol MC; McGuigan KA; Verbrugge RR; Epstein RS
    Med Care; 2005 Jun; 43(6):521-30. PubMed ID: 15908846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.
    Piette JD; Heisler M; Ganoczy D; McCarthy JF; Valenstein M
    Psychiatr Serv; 2007 Feb; 58(2):207-12. PubMed ID: 17287377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of medication adherence in patients with type 2 diabetes mellitus.
    Curkendall SM; Thomas N; Bell KF; Juneau PL; Weiss AJ
    Curr Med Res Opin; 2013 Oct; 29(10):1275-86. PubMed ID: 23815104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allopurinol adherence among patients with gout: an Italian general practice database study.
    Mantarro S; Capogrosso-Sansone A; Tuccori M; Blandizzi C; Montagnani S; Convertino I; Antonioli L; Fornai M; Cricelli I; Pecchioli S; Cricelli C; Lapi F
    Int J Clin Pract; 2015 Jul; 69(7):757-65. PubMed ID: 25683693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study.
    Janssens HJ; Arts PG; Schalk BW; Biermans MC
    Joint Bone Spine; 2017 Jan; 84(1):59-64. PubMed ID: 27236260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US.
    Hepp Z; Lage MJ; Espaillat R; Gossain VV
    J Med Econ; 2018 Sep; 21(9):912-919. PubMed ID: 29865926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses.
    Vanelli M; Pedan A; Liu N; Hoar J; Messier D; Kiarsis K
    Clin Ther; 2009 Nov; 31(11):2628-52. PubMed ID: 20110007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects and Factors Related to Adherence to A Diabetes Pay-for-Performance Program: Analyses of a National Health Insurance Claims Database.
    Chi MJ; Chou KR; Pei D; Hwang JS; Quinn L; Chung MH; Liao YM
    J Am Med Dir Assoc; 2016 Jul; 17(7):613-9. PubMed ID: 27073041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
    Zandman-Goddard G; Amital H; Shamrayevsky N; Raz R; Shalev V; Chodick G
    Rheumatology (Oxford); 2013 Jun; 52(6):1126-31. PubMed ID: 23392592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association among change in medical costs, level of comorbidity, and change in adherence behavior.
    Kymes SM; Pierce RL; Girdish C; Matlin OS; Brennan T; Shrank WH
    Am J Manag Care; 2016 Aug; 22(8):e295-301. PubMed ID: 27556832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance among three self-reported measures of medication adherence and pharmacy refill records.
    Cook CL; Wade WE; Martin BC; Perri M
    J Am Pharm Assoc (2003); 2005; 45(2):151-9. PubMed ID: 15868757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study.
    Huang CF; Liu JC; Huang HC; Chuang SY; Chen CI; Lin KC
    Rheumatol Int; 2017 Feb; 37(2):313-322. PubMed ID: 28004164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
    Ye X; Qian C; Liu J; St Peter WL
    Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study.
    Wong MC; Jiang JY; Griffiths SM
    Clin Ther; 2009 Oct; 31(10):2170-7; discussion 2150-1. PubMed ID: 19922888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.